Supernus Pharmaceuticals Files 2024 10-K
Ticker: SUPN · Form: 10-K · Filed: Feb 25, 2025 · CIK: 1356576
| Field | Detail |
|---|---|
| Company | Supernus Pharmaceuticals, Inc. (SUPN) |
| Form Type | 10-K |
| Filed Date | Feb 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-K, annual-report, pharmaceuticals
TL;DR
SUPN filed its 2024 10-K. All systems go for pharma giant.
AI Summary
Supernus Pharmaceuticals, Inc. filed its 2024 10-K on February 25, 2025, reporting on its fiscal year ending December 31, 2024. The company, headquartered in Rockville, MD, operates in the pharmaceutical preparations sector. This filing provides a comprehensive overview of its financial performance, business operations, and risk factors for the year.
Why It Matters
This filing is crucial for investors and analysts to understand Supernus Pharmaceuticals' financial health, strategic direction, and potential risks as of the end of the 2024 fiscal year.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, Supernus faces inherent risks related to drug development, regulatory approvals, market competition, and intellectual property.
Key Players & Entities
- SUPERNUS PHARMACEUTICALS, INC. (company) — Filer
- 2024-12-31 (date) — Fiscal Year End
- 2025-02-25 (date) — Filing Date
- Rockville, MD (location) — Business Address
- 2834 (industry_code) — Standard Industrial Classification (Pharmaceutical Preparations)
FAQ
What is the primary business of Supernus Pharmaceuticals, Inc.?
Supernus Pharmaceuticals, Inc. is primarily involved in the pharmaceutical preparations industry, as indicated by its SIC code 2834.
When did Supernus Pharmaceuticals, Inc. file its 10-K report for the fiscal year 2024?
The 10-K report for the fiscal year ending December 31, 2024, was filed on February 25, 2025.
Where is Supernus Pharmaceuticals, Inc. headquartered?
Supernus Pharmaceuticals, Inc. is headquartered at 9715 Key West Avenue, Rockville, MD 20850.
What is the SEC file number for Supernus Pharmaceuticals, Inc.?
The SEC file number for Supernus Pharmaceuticals, Inc. is 001-35518.
What is the fiscal year end for Supernus Pharmaceuticals, Inc.?
The fiscal year end for Supernus Pharmaceuticals, Inc. is December 31.
Filing Details
This Form 10-K (Form 10-K) was filed with the SEC on February 25, 2025 regarding SUPERNUS PHARMACEUTICALS, INC. (SUPN).